239 related articles for article (PubMed ID: 37227679)
1. Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receive.
Verso M; Muñoz A; Connors JM
Intern Emerg Med; 2023 Sep; 18(6):1619-1634. PubMed ID: 37227679
[TBL] [Abstract][Full Text] [Related]
2. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence.
Jiménez-Fonseca P; Gallardo E; Arranz Arija F; Blanco JM; Callejo A; Lavin DC; Costa Rivas M; Mosquera J; Rodrigo A; Sánchez Morillas R; Vares Gonzaléz M; Muñoz A; Carmona-Bayonas A
Eur J Intern Med; 2022 Jun; 100():33-45. PubMed ID: 35227541
[TBL] [Abstract][Full Text] [Related]
3. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
Aikens GB; Rivey MP; Hansen CJ
Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
[TBL] [Abstract][Full Text] [Related]
4. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
[TBL] [Abstract][Full Text] [Related]
5. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
[TBL] [Abstract][Full Text] [Related]
6. New strategies of VTE prevention in cancer patients.
Verso M; Agnelli G
Thromb Res; 2014 May; 133 Suppl 2():S128-32. PubMed ID: 24862133
[TBL] [Abstract][Full Text] [Related]
7. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D; Debourdeau P; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Bounameaux H; Büller HR
J Thromb Haemost; 2013 Jan; 11(1):56-70. PubMed ID: 23217107
[TBL] [Abstract][Full Text] [Related]
8. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Otten HM; Rutjes AW
Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years.
Tufano A; Brenner B
Semin Thromb Hemost; 2024 Feb; 50(1):96-103. PubMed ID: 37201536
[TBL] [Abstract][Full Text] [Related]
10. Primary prophylaxis of VTE in cancer outpatients.
Imberti D; Benedetti R
Thromb Res; 2016 Apr; 140 Suppl 1():S103-8. PubMed ID: 27067962
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
13. [Thromboprophylaxis in ambulatory patients with cancer].
Hart C; Heudobler D; Linnemann B
Dtsch Med Wochenschr; 2020 Feb; 145(3):130-134. PubMed ID: 32018283
[TBL] [Abstract][Full Text] [Related]
14. Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?
Pabinger I; Ay C
Hamostaseologie; 2012; 32(2):132-7. PubMed ID: 21822526
[TBL] [Abstract][Full Text] [Related]
15. Management of venous thromboembolism in patients with cancer.
Agnelli G; Verso M
J Thromb Haemost; 2011 Jul; 9 Suppl 1():316-24. PubMed ID: 21781268
[TBL] [Abstract][Full Text] [Related]
16. Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism.
Liew NC; Alemany GV; Angchaisuksiri P; Bang SM; Choi G; DE Silva DA; Hong JM; Lee L; Li YJ; Rajamoney GN; Suviraj J; Tan TC; Tse E; Teo LT; Visperas J; Wong RS; Lee LH
Int Angiol; 2017 Feb; 36(1):1-20. PubMed ID: 27606807
[TBL] [Abstract][Full Text] [Related]
17. Update on Guidelines for the Prevention of Cancer-Associated Thrombosis.
Elshoury A; Schaefer JK; Lim MY; Skalla DP; Streiff MB
J Natl Compr Canc Netw; 2022 Jun; 20(13):. PubMed ID: 35728777
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis of venous thromboembolism in cancer patients.
Frere C; Doucet L; Farge D
Expert Rev Hematol; 2016 Jun; 9(6):535-9. PubMed ID: 27031534
[TBL] [Abstract][Full Text] [Related]
19. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
[TBL] [Abstract][Full Text] [Related]
20. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
Lyman GH; Khorana AA; Falanga A; Clarke-Pearson D; Flowers C; Jahanzeb M; Kakkar A; Kuderer NM; Levine MN; Liebman H; Mendelson D; Raskob G; Somerfield MR; Thodiyil P; Trent D; Francis CW;
J Clin Oncol; 2007 Dec; 25(34):5490-505. PubMed ID: 17968019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]